MYD88 and systemic lupus erythematosus: (17) constructed a murine model of lupus with TLR9 point mutations that either hinder ligand binding(Tlr9K51E) or MyD88 signalling (Tlr9P915H) and subsequently detected the effects of these mutations on the lupus phenotype.